Q98440743

Summary

Q98440743 is an interpellation^[1].

Key Facts

• Q98440743 authored Tomas Eneroth^[2].
• Q98440743's instance of is recorded as interpellation^[3].
• Q98440743's part of the series is recorded as interpellations of the 2009/10 legislative session of the Riksdag^[4].
• Q98440743's language of work or name is recorded as Swedish^[5].
• Q98440743's publication date is recorded as +2010-02-05T00:00:00Z^[6].
• Q98440743's significant event is recorded as debate^[7].
• Q98440743's main subject is recorded as medication^[8].
• Q98440743's work available at URL is recorded as http://data.riksdagen.se/dokument/GX10228^[9].
• Q98440743's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GX10228^[10].
• Q98440743's applies to jurisdiction is recorded as Sweden^[11].
• Q98440743's legal citation of this text is recorded as ip. 2009/10:228^[12].
• Q98440743's title is recorded as Regeringens hantering av krisen inom läkemedelsindustrin^[13].
• Q98440743's addressee is recorded as Maud Olofsson^[14].
• Q98440743's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98440743's copyright status is recorded as public domain^[16].
• Q98440743's Swedish Riksdag document ID is recorded as GX10228^[17].

Body

Works and Contributions

Q98440743 authored Tomas Eneroth^[2].